Press Releases
DrFirst Introduces Innovative Medication Management Solutions For MEDITECH
DrFirst, the market leader in delivering intelligent medication management solutions that improve patient safety, announced innovations that enhance data quality, improve clinical workflow and deliver...
News
Community Health Systems Announces Definitive Agreement to Divest Five Pennsylvania Hospitals
Community Health Systems, Inc announced that subsidiaries of the Company have signed a definitive agreement to sell five Pennsylvania hospitals and their associated assets to subsidiaries...
Press Releases
Healthcare Industry Springs to Life at the World’s Largest Healthcare Event – tHIS Event
The Health Industry Summit (tHIS) 2017 hosted by China and organized by Reed Sinopharm, opened in Shanghai at the National Exhibition and Convention Center...
Press Releases
Stimwave Receives CE Mark Approval for World First Fully Percutaneous Stimulator Anchoring System
Freedom Neuro BV, a medical device distributor for Stimwave Technologies Incorporated announced CE Mark approval for the world’s first Percutaneous Injectable Anchor System.
The injectable anchor...
News
Sunovion Receives CRL from FDA for SUN-101e Flow New Drug Application for COPD
Sunovion Pharmaceuticals Inc announced that the U.S. FDA issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for SUN-101/eFlow® (glycopyrrolate) for...
Press Releases
A successful Paris healthcare week 2017
Paris Healthcare Week is a unique European event that brings together professionals from the healthcare and autonomy sectors. This year's event once again offered...
Press Releases
FDA approves Roche Actemra/RoActemra (tocilizumab) for giant cell arteritis
Roche announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) ) subcutaneous injection for the treatment of GCA, a chronic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read